Maintenance / Service

PRODUCTS

  • Phenogel™ Organic GPC/SEC Columns

    Enhance Resolution for Polymer Analysis using Non-Aqueous GPC/SEC

    Phenogel™ size exclusion columns for gel permeation chromatography (GPC) are composed of highly cross-linked styrene-divinylbenzene (SDVB) and achieve high resolution and tight linear calibration curves. Phenogel™ is available in seven different pore sizes, ranging from 50 Å to 106 Å; and a linear bed configuration. Pore size distribution and pore volume are closely controlled parameters in the manufacturing process accounting for the high resolution, tight linear calibration curves, and excellent column-to-column reproducibility. USP L21 packings available.

    • 5 and 10 µm particle sizes
    • Narrow bore (4.6 mm ID) solvent-saver columns available
    • Highly cross-linked for mechanical and chemical stability
    • Temperature stable to 140 °C.
  • Modern clinical trials require modern technology. Leverage the flexibility and speed of the cloud with TrialKit electronic data capture (EDC).

  • A Transfection Solution for Gram-Scale Protein Production

    The ExPERT VLx system delivers unmatched transfection scalability with MaxCyte's Flow Electroporation® technology for industry-leading reproducibility, flexibility and ease of use.

    • Reduce time, cost and risk
    • Transfect up to 200 billion cells, in a single-use system, in less than 30 minutes
    • Obtain grams of proteins in weeks, not months
    • Achieve reproducible results, superior transfection efficiency, cell viability and protein expression
    • Scale seamlessly to expedite your transition from discovery to Phase 1
    • Proprietary Flow Electroporation® Technology
  • The most widely trusted solution for clinical trial disclosure management

    Managing clinical trial disclosures can be tedious and error-prone, opening the door to noncompliance. TrialScope Disclose provides a better way.

    Our centralized platform automates data entry and reporting for Clinicaltrials.gov, CTIS, and more. This reduces manual effort so you can focus on bringing new treatments to patients, not paperwork.

  • Seamlessly delivering your virotherapy

    With industry-leading viral expertise, ReciBioPharm navigates the rapidly evolving field of virotherapy to support the development and manufacturing of your gene therapies, viral vector vaccines and oncolytic viruses (OVs).

WHITE PAPERS AND CASE STUDIES

NEWS